Literature DB >> 5505677

The distribution of plasma phenytoin levels in epileptic patients.

P T Lascelles, R S Kocen, E H Reynolds.   

Abstract

Plasma phenytoin levels were estimated in 111 adult epileptic patients. A wide scatter of values was found, with over half outside the therapeutic limits of 10 to 20 μg/ml. Phenytoin tolerance tests carried out in five patients revealed a possible failure to metabolize the drug adequately in three of them. Factors affecting the plasma phenytoin level are discussed. The importance of this assay is seen in view of the number of patients potentially at risk from toxic blood levels in the absence of accepted clinical manifestations of acute or subacute intoxication.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5505677      PMCID: PMC493508          DOI: 10.1136/jnnp.33.4.501

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  25 in total

1.  Dicoumarol-induced diphenylhydantoin intoxication.

Authors:  J M Hansen; M Kristensen; L Skovsted; L K Christensen
Journal:  Lancet       Date:  1966-07-30       Impact factor: 79.321

2.  Sulthiame (Ospolot) as inhibitor of diphenylhydatoin metabolism.

Authors:  J M Hansen; M Kristensen; L Skovsted
Journal:  Epilepsia       Date:  1968-03       Impact factor: 5.864

3.  Studies of anticonvulsant levels in epileptics. I. Serum diphenylhydantoin concentrations in a group of medically indigent outpatients.

Authors:  A F Haerer; J B Grace
Journal:  Acta Neurol Scand       Date:  1969       Impact factor: 3.209

4.  Management of epilepsy with diphenylhydantoin sodium. Dosage regulation for problem patients.

Authors:  H Kutt; F McDowell
Journal:  JAMA       Date:  1968-03-11       Impact factor: 56.272

5.  The effect of phenobarbital on plasma diphenylhydantoin level and metabolism in man and in rat liver microsomes.

Authors:  H Kutt; J Haynes; K Verebely; F McDowell
Journal:  Neurology       Date:  1969-06       Impact factor: 9.910

6.  The influence of disulfiram and calcium carbimide on the serum diphenylhydantoin. Excretion of HPPH in the urine.

Authors:  O V Olesen
Journal:  Arch Neurol       Date:  1967-06

7.  Depression of prahydroxylation of diphenylhydantoin by antituberculosis chemotherapy.

Authors:  H Kutt; W Winters; F H McDowell
Journal:  Neurology       Date:  1966-06       Impact factor: 9.910

8.  Some causes of ineffectiveness of diphenylhydantoin.

Authors:  H Kutt; J Haynes; F McDowell
Journal:  Arch Neurol       Date:  1966-05

9.  Phenytoin (Dilantin) intoxication.

Authors:  E Frantzen; J M Hansen; O E Hansen; M Kristensen
Journal:  Acta Neurol Scand       Date:  1967       Impact factor: 3.209

10.  Supervision of epileptic patients taking phenytoin.

Authors:  F B Gibberd; J F Dunne; A J Handley; B L Hazleman
Journal:  Br Med J       Date:  1970-01-17
View more
  9 in total

1.  The value of serum diphenylhydantoin (phenytoin) levels in the management of epilepsy.

Authors:  E H Reynolds
Journal:  Proc R Soc Med       Date:  1975-02

Review 2.  Adverse neuropsychiatric effects of anticonvulsant drugs.

Authors:  E H Reynolds; M R Trimble
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

3.  Potentially lethal interaction of cimetidine and morphine.

Authors: 
Journal:  Can Med Assoc J       Date:  1981-12-01       Impact factor: 8.262

4.  Effect of age, height, weight and sex on serum phenytoin concentration in epileptic patients.

Authors:  G W Houghton; A Richens; M Leighton
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

Review 5.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

6.  Phenytoin dosage in ambulant epileptic patients.

Authors:  C Terrence; M Alberts
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-05       Impact factor: 10.154

Review 7.  Clinical pharmacokinetics of phenytoin.

Authors:  A Richens
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

Review 8.  The role of therapeutic drug monitoring in improving the cost effectiveness of anticonvulsant therapy.

Authors:  M J Eadie
Journal:  Clin Pharmacokinet       Date:  1995-07       Impact factor: 6.447

9.  Serum phenytoin concentration and clinical response in patients with epilepsy.

Authors:  D J Gannaway; G E Mawer
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.